Crush The Market

undefined Logo

Alexion Pharmaceuticals, Inc.

182.50 USD

+0.00%

Add To Watchlist

Value

51

Growth

62

Financials

72

Social Sentiment

0

Analyst Recomendation

86

Total

68

All Scores Out Of 100

*Not Investment Advice

Social Sentiment

Twitter Sentiment Score Logo

N/A

Stocktwits Sentiment Score Logo

N/A

Financials

Piotroski Score

7

Altman Z Score

5

Key Figures

PE Ratio

66.61

Margin Of Safety (DFC)

N/A

Revenue Growth (5 Year Average)

16.24%

Ratings Consensus

Strong Buy

Share Buybacks

0.72%

Current Ratio

3.59

Analyst Grades

Morgan Stanley

Equal-Weight

Stifel Nicolaus

Hold

BTIG Research

Neutral

SunTrust Robinson Humphrey

Buy

Credit Suisse

Outperform

Barclays

Overweight

Crush The Market

We Use Cookies